Korro Bio, Inc. (KRRO) Stock Forecast & Price Target
Korro Bio, Inc. · NASDAQ
$13.49+1.25 (+10.21%)
15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 11 firms covering Korro Bio, Inc, 9 rate it Buy or better, 2 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. The target range is very wide, $8.00 to $30.00 (about 3.8x), which points to deep disagreement over how to value the company rather than near-term timing. The average target of $19.33 sits 43% above the current $13.49. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-1.36 next quarter toward $-4.46 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS11 ratings
Strong Buy
Strong Buy00%
Buy982%
Hold218%
Sell00%
Strong Sell00%
Based on 11 analysts giving stock ratings to Korro Bio, Inc.
As of Sep, 9 of 11 firms rate KRRO a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
KRRO EPS & revenue forecast
EPS · NEXT QUARTER
$-1.36
Range $-2.44 – $-0.74 · 10 analysts · -17% YoY
Next period, 10 analysts expect Korro Bio, Inc. to earn $-1.36 a share (range $-2.44 – $-0.74), versus $-1.65 a year earlier. Full-year consensus is $-5.18, growing to $-4.46 the year after.
REVENUE · NEXT QUARTER
$166.7K
Range $0 – $1.5M · 10 analysts · -87% YoY
Revenue is expected to reach $166.7K (range $0 – $1.5M), -87.1% year-over-year. Full-year consensus is $333.3K, rising to $1.1M next year.
Top analysts covering Korro Bio, Inc.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on KRRO.
#1
Luca Issi
RBC Capital · Rank #1
Hold
$8.00-40.7% to target
Overall win rate
55%
+ Follow
#2
Keay Nakae
Chardan Capital · Rank #89
Buy
$15.00+11.2% to target
Overall win rate
43%
+ Follow
#3
Yasmeen Rahimi
Piper Sandler · Rank #188
Buy
$30.00+122.4% to target
Overall win rate
33%
+ Follow
#4
Mitchell Kapoor
HC Wainwright & Co. · Rank #193
Buy
$15.00+11.2% to target
Overall win rate
34%
+ Follow
#5
Andreas Argyrides
Oppenheimer · Rank #242
Buy
$90.00+567.2% to target
Overall win rate
45%
+ Follow
KRRO stock forecast FAQ
What is KRRO's average 12-month price target?+
The 9 analysts with a live target average $19.33 for Korro Bio, Inc. over the next 12 months, ranging from a $30.00 high to a $8.00 low.
Is KRRO stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 11 analyst ratings, 9 are Buy or Strong Buy, 2 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for KRRO?+
The Street-high target is $30.00 (Piper Sandler), and the Street-low is $8.00 (RBC Capital). The average of all 9 active targets is $19.33.
How many Wall Street analysts cover KRRO?+
11 analysts have an active rating on Korro Bio, Inc., and 9 firms carry a live 12-month price target.
Who is the most accurate analyst covering KRRO?+
Among analysts who currently cover KRRO, Luca Issi of RBC Capital has the strongest overall Quantellect track record (Rank #1). Their current call is Hold with a $8.00 target.
What is Korro Bio, Inc.'s projected EPS for next quarter?+
The consensus estimate is $-1.36 per share (range $-2.44 – $-0.74) across 10 analysts. Full-year EPS is projected at $-5.18, rising to $-4.46 the following year.
How much revenue is Korro Bio, Inc. expected to report next quarter?+
Consensus revenue is $166.7K (range $0 – $1.5M). Full-year revenue is projected at $333.3K, growing to $1.1M next year.
Have analysts been upgrading or downgrading KRRO lately?+
As of Sep, 9 of 11 firms rate KRRO a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their KRRO calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
